You Are Here:
Clinical Summary of U.S. Preventive Services Task Force Recommendation
This document is a summary of the 2009 recommendation of the U.S. Preventive Services Task Force on screening of infants for hyperbilirubinemia. It is intended for use by primary care clinicians. This summary was first published in Pediatrics in October 2009 (Pediatrics 2009;124(4):1173).
|Population||Healthy Newborn Infants ≥35 weeks' gestational age|
|No recommendation due to insufficient evidence.|
Risk factors for hyperbilirubinemia include family history of neonatal jaundice, exclusive breastfeeding, bruising, cephalohematoma, ethnicity (Asian, black), maternal age >25 years, male gender, G6PD deficiency, and gestational age <36 weeks.
Chronic bilirubin encephalopathy is a rare but devastating condition. Not all children with chronic bilirubin encepahalopathy have a history of hyperbilirubinemia.
|Rationale for No Recommendation||
Evidence about the benefits and harms of screening is lacking. Therefore, the USPSTF could not determine the balance of benefits and harms of screening newborns for hyperbilirubinemia to prevent chronic bilirubin encephalopathy.
|Considerations for Practice||
In deciding whether to screen, clinicians should consider the following:
Screening may consist of risk-factor assessment, measurement of bilirubin level either in serum or by transcutaneous estimation, or a combination of methods.
Phototherapy is commonly used to treat hyperbilirubinemia.
|Relevant USPSTF Recommendations||
USPSTF recommendations on screening newborns for hearing loss, congenital hypothyroidism, hemoglobinopathies, and phenylketonuria (PKU) can be found at http://www.uspreventiveservicestaskforce.org.
For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement, and supporting documents please go to http://www.uspreventiveservicestaskforce.org.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Copyright and Source Information
This document is in the public domain within the United States.
Requests for linking or to incorporate content in electronic resources should be sent via the USPSTF contact form.
AHRQ Publication No. 10-05140-EF-3
Current as of October 2009
U.S. Preventive Services Task Force. Screening of Infants for Hyperbilirubinemia To Prevent Chronic Bilirubin Encephalopathy: Clinical Summary of U.S. Preventive Services Task Force Recommendation. AHRQ Publication No. 10-05140-EF-3, October 2009. http://www.uspreventiveservicestaskforce.org/uspstf09/hyperbilirubinemia/hyperbsum.htm